Poster Presentation The Pancreas Summit 2025

The international use of radiology synoptic report in pancreatic caner: a literature review (#14)

Ariadna Recasens 1 , Chen Wang 1 , Samantha Ellis 2 3 , Lin Li 1 , John Zalcberg 1 4 , Charles Pilgrim 1 3 5
  1. School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia
  2. Department of Radiology, Alfred Health, Melbourne, VIC, Australia
  3. Department of Surgery, School of Translational Medicine, Monash University, Melbourne, VIC, Australia
  4. Department of Medical Oncology, Alfred Health, Melbourne, VIC, Australia
  5. Hepatopancreaticobiliary Surgery, Alfred Health, Melbourne, Australia

Objective: Several professional societies recommend the use of a synoptic radiology report (SRR) to report key radiological findings of patients with pancreatic cancer. This review aims to evaluate the global trends in SRR usage in pancreatic cancer.

Methods: EMBASE and Medline databases were searched to identify studies of interest. The search results were uploaded to Covidence. Initially, titles and abstracts were independently screened by two reviewers. After resolving conflicts, the reviewers performed a second independent screening, reading the full texts. Data from the included papers were extracted using spreadsheets and tables.

Results: Ten research articles describing the use of SRR for pancreatic cancer and five guidelines/consensus recommending its usage were included in the review [1-15]. Five articles were from the United States (US), two from Australia, one from the United Kingdom, one from Italy and one from Canada. Guidelines from the Society of Abdominal Radiology, American Pancreatic Association and National Comprehensive Cancer Network were the most frequently used to develop SRR. There was a wide variety of SRR usage at the baseline level (i.e., before any intervention to implement SRR), varying from 0 to 59%.  Two interventions to increase the use of SRR in their corresponding institutions were proven successful. Benefits of using SRR compared to prose reports included: increased number of reported key tumour features, increased interobserver agreement, increased odds of pancreatic cancer diagnosis within 120 days of imaging, reduced odds of increased vascular involvement during multidisciplinary review and an increase in the accuracy and efficacy of the surgeon’s decision regarding resectability status. A US survey found that the most common reasons radiologists were not using SRR included: interference with efficient workflow or slowing down reporting, a lack of interest among radiologists and complexity of existing SRR templates.  Suggested solutions provided by the respondents of the survey to improve the implementation of SRR included: simplifying SRR templates, creating new templates based on expert consensus and increasing educational efforts.

Discussion: Use of SRR in pancreatic cancer is associated with several benefits. However, the implementation of SRR will only succeed when radiologists have access to tools that satisfy their needs.

 

  1. Bhayana R, Nanda B, Dehkharghanian T, Deng Y, Bhambra N, Elias G, Datta D, Kambadakone A, Shwaartz CG, Moulton CA, Henault D, Gallinger S, Krishna S. Large Language Models for Automated Synoptic Reports and Resectability Categorization in Pancreatic Cancer. Radiology. 2024 Jun;311(3):e233117.
  2. Ormsby EL, Kojouri K, Chang PC, Lin TY, Vuong B, Ramirez RM, Schueler KM, Sweet CF, Herrinton LJ. Association of Standardized Radiology Reporting and Management of Abdominal CT and MRI With Diagnosis of Pancreatic Cancer. Clin Gastroenterol Hepatol. 2023 Mar;21(3):644-652.e2.
  3. Hodnett R, MacCormick A, Ibrahim R, Miles G, Puckett M, Aroori S. Use of a standardized reporting template: can we improve report quality in pancreatic and peri-ampullary malignancy? ANZ J Surg. 2022 Jan;92(1-2):109-113.
  4. Malik RF, Hasanain A, Lafaro KJ, He J, Narang AK, Fishman EK, Zaheer A. Structured CT reporting of pancreatic ductal adenocarcinoma: impact on completeness of information and interdisciplinary communication for surgical planning. Abdom Radiol (NY). 2022 Feb;47(2):704-714.
  5. Gonda TA, Farrell J, Wallace M, Khanna L, Janec E, Kwon R, Saunders M, Siddiqui UD, Brand R, Simeone DM; PRECEDE Consortium. Standardization of EUS imaging and reporting in high-risk individuals of pancreatic adenocarcinoma: consensus statement of the Pancreatic Cancer Early Detection Consortium. Gastrointest Endosc. 2022 Apr;95(4):723-732.e7.
  6. Pilgrim CHC, Maciejewska A, Ayres N, Ellis S, Goodwin M, Zalcberg JR, Haydon A. Synoptic CT scan reporting of pancreatic adenocarcinoma to align with international consensus guidelines on surgical resectability: a Victorian pilot. ANZ J Surg. 2022 Oct;92(10):2565-2570.
  7. Dromain C, Vullierme MP, Hicks RJ, Prasad V, O'Toole D, de Herder WW, Pavel M, Faggiano A, Kos-Kudla B, Öberg K, Krejs GJ, Grande E, Niederle B, Sundin A. ENETS standardized (synoptic) reporting for radiological imaging in neuroendocrine tumours. J Neuroendocrinol. 2022 Mar;34(3):e13044.
  8. Huang C, Simeone DM, Luk L, Hecht EM, Khatri G, Kambadakone A, Chandarana H, Ream JM, Everett JN, Guimaraes A, Liau J, Dasyam AK, Harmath C, Megibow AJ; PRECEDE Consortium. Standardization of MRI Screening and Reporting in Individuals With Elevated Risk of Pancreatic Ductal Adenocarcinoma: Consensus Statement of the PRECEDE Consortium. AJR Am J Roentgenol. 2022 Dec;219(6):903-914.
  9. Grogan A, Loveday B, Michael M, Wong HL, Gibbs P, Thomson B, Lee B, Ko HS. Real-world staging computed tomography scanning technique and important reporting discrepancies in pancreatic ductal adenocarcinoma. ANZ J Surg. 2022 Jul;92(7-8):1789-1796.
  10. Granata V, Morana G, D'Onofrio M, Fusco R, Coppola F, Grassi F, Cappabianca S, Reginelli A, Maggialetti N, Buccicardi D, Barile A, Rengo M, Bortolotto C, Urraro F, La Casella GV, Montella M, Ciaghi E, Bellifemine F, De Muzio F, Danti G, Grazzini G, Barresi C, Brunese L, Neri E, Grassi R, Miele V, Faggioni L. Structured Reporting of Computed Tomography and Magnetic Resonance in the Staging of Pancreatic Adenocarcinoma: A Delphi Consensus Proposal. Diagnostics (Basel). 2021 Nov 3;11(11):2033.
  11. Dimarco M, Cannella R, Pellegrino S, Iadicola D, Tutino R, Allegra F, Castiglione D, Salvaggio G, Midiri M, Brancatelli G, Vernuccio F. Impact of structured report on the quality of preoperative CT staging of pancreatic ductal adenocarcinoma: assessment of intra- and inter-reader variability. Abdom Radiol (NY). 2020 Feb;45(2):437-448.
  12. Persigehl T, Baumhauer M, Baeßler B, Beyer LP, Bludau M, Bruns C, Bunck AC, Germer CT, Grenacher L, Hackländer T, Haneder S, Heinrich S, Heusch P, Hoffmann M, Juchems MS, Kröger JR, Kotter E, Layer G, Maintz D, Menke J, et al.,. Structured Reporting of Solid and Cystic Pancreatic Lesions in CT and MRI: Consensus-Based Structured Report Templates of the German Society of Radiology (DRG). Rofo. 2020 Jul;192(7):641-656
  13. Kambadakone AR, Zaheer A, Le O, Bhosale P, Meier J, Guimaraes AR, Shah Z, Hough DM, Mannelli L, Soloff E, Friedman A, Tamm E. Multi-institutional survey on imaging practice patterns in pancreatic ductal adenocarcinoma. Abdom Radiol (NY). 2018 Feb;43(2):245-252.
  14. Al-Hawary MM, Francis IR, Chari ST, Fishman EK, Hough DM, Lu DS, Macari M, Megibow AJ, Miller FH, Mortele KJ, Merchant NB, Minter RM, Tamm EP, Sahani DV, Simeone DM. Pancreatic ductal adenocarcinoma radiology reporting template: consensus statement of the Society of Abdominal Radiology and the American Pancreatic Association. Radiology. 2014 Jan;270(1):248-60.
  15. Brook OR, Brook A, Vollmer CM, Kent TS, Sanchez N, Pedrosa I. Structured reporting of multiphasic CT for pancreatic cancer: potential effect on staging and surgical planning. Radiology. 2015 Feb;274(2):464-72.